UID,image,title,institution,speaker,bio,abstract,slideslive_id,slideslive_active_date
P01,static/images/speakers/david_meltzer.jpg,"",University of Chicago,David O. Meltzer,"David O. Meltzer is Chief of the Section of Hospital Medicine, Director of the Center for Health and the Social Sciences, and Chair of the Committee on Clinical and Translational Science at the University of Chicago, where he is Professor in the Department of Medicine, and affiliated faculty at the University of Chicago Harris School of Public Policy and the Department of Economics. Dr. Meltzer’s research explores problems in health economics and public policy with a focus on the theoretical foundations of medical cost-effectiveness analysis and the cost and quality of hospital care. He is currently leading a Centers for Medicaid and Medicare Innovation Challenge award to study the effects of improved continuity in the doctor patient relationship between the inpatient and outpatient setting on the costs and outcomes of care for frequently hospitalized Medicare patients. He led the formation of the Chicago Learning Effectiveness Advancement Research Network (Chicago LEARN) that helped pioneer collaboration of Chicago-Area academic medical centers in hospital-based comparative effectiveness research and the recent support of the Chicago Area Patient Centered Outcomes Research Network (CAPriCORN) by the Patient Centered Outcomes Research Institute (PCORI).
<p>
Meltzer received his MD and PhD in economics from the University of Chicago and completed his residency in internal medicine at Brigham and Women’s Hospital in Boston. Meltzer is the recipient of numerous awards, including the Lee Lusted Prize of the Society for Medical Decision Making, the Health Care Research Award of the National Institute for Health Care Management, and the Eugene Garfield Award from Research America. Meltzer is a research associate of the National Bureau of Economic Research, elected member of the American Society for Clinical Investigation, and past president of the Society for Medical Decision Making. He has served on several IOM panels, include one examining U.S. organ allocation policy and the recent panel on the Learning Health Care System that produced Best Care at Lower Cost. He also has served on the DHHS Secretary’s Advisory Committee on Healthy People 2020, the Patient Centered Outcomes Research Institute (PCORI) Methodology Committee, as a Council Member of the National Institute for General Medical Studies, and as a health economics advisor for the Congressional Budget Office.</p>","",,
P02,static/images/speakers/kyra_gan.png,"",Cornell University,Kyra Gan,"Kyra Gan is an Assistant Professor in the School of Operations Research and Information Engineering and Cornell Tech at Cornell University. Her research interests include adaptive/online algorithm design in personalized treatment (including micro-randomized trials and N-of-1 trials) under constraint settings, computerized/automated inference methods (e.g., targeted learning with RKHS), robust causal discovery in medical data, and fairness in organ transplants. More broadly, she is interested in bridging the gap between research and practice in healthcare.
<p>
Prior to Cornell Tech, she was a postdoctoral fellow at the Statistical Reinforcement Lab at Harvard University. She received her Ph.D. in Operations Research in 2022 from Carnegie Mellon University at the Tepper School of Business. She received her B.A.s in Mathematics and Economics from Smith College in 2017. She is a recipient of the 2021 Pierskalla Best Paper Award and the 2021 CHOW Best Student Paper Award in the Category of Operations Research and Management Science.</p>","",,
P03,static/images/speakers/girish_nadkarni.png,"",Mount Sinai,Girish N. Nadkarni,"Girish N. Nadkarni, MD, MPH, is the Irene and Dr. Arthur M. Fishberg Professor of Medicine at the Icahn School of Medicine at Mount Sinai. As an expert physician-scientist, Dr. Nadkarni bridges the gap between comprehensive clinical care and innovative research. He is the System Chief of the Division of Data Driven and Digital Medicine (D3M), the Co-Director of the Mount Sinai Clinical Intelligence Center (MSCIC) and the Director of  Charles Bronfman Institute for Personalized Medicine.
<p>
Before completing his medical degree at one of the top-ranked medical colleges in India, Dr. Nadkarni received training in mathematics. He then received a master’s degree in public health at the Johns Hopkins Bloomberg School of Public Health, and then was a research associate at the Johns Hopkins Medical Institute. Dr. Nadkarni completed his residency in internal medicine and his clinical fellowship in nephrology at the Icahn School of Medicine at Mount Sinai. He then completed a research fellowship in personalized medicine and informatics.
</p>
Dr. Nadkarni has authored more than 240 peer-reviewed scientific publications, including articles in the New England Journal of Medicine, the Journal of the American Medical Association, the Annals of Internal Medicine and Nature Medicine. Dr. Nadkarni is the principal or co-investigator for several grants funded by the National Institutes of Health focusing on informatics, data science, and precision medicine. He is also one of the multiple principal investigators of the NIH RECOVER consortium focusing on the long-term sequelae of COVID-19. He has several patents and is also the scientific co-founder of investor-backed companies—one of which, Renalytix, is listed on NASDAQ. In recognition of his work as an active clinician and investigator, he has received several awards and honors, including the Dr. Harold and Golden Lamport Research Award, the Deal of the Year award from Mount Sinai Innovation Partners, the Carl Nacht Memorial Lecture, and the Rising Star Award from ANIO.","",,
P04,static/images/speakers/roy_perlis.jpeg,"",Massachusetts General Hospital,Roy Perlis,"Roy Perlis, MD MSc is Associate Chief for Research in the Department of Psychiatry and Director of the Center for Quantitative Health at Massachusetts General Hospital. He is Professor of Psychiatry at Harvard Medical School and Associate Editor at JAMA's open-access journal, JAMA Network - Open. Dr. Perlis graduated from Brown University, Harvard Medical School and Harvard School of Public Health, and completed his residency, chief residency, and clinical/research fellowship at MGH before joining the faculty. Dr. Perlis's research is focused on identifying predictors of treatment response in brain diseases, and using these biomarkers to develop novel treatments. Dr. Perlis has authored more than 350 articles reporting original research, in journals including Nature Genetics, Nature Neuroscience, JAMA, NEJM, the British Medical Journal, and the American Journal of Psychiatry. His research has been supported by awards from NIMH, NHGRI, NHLBI, NICHD, NCCIH, and NSF, among others. In 2010 Dr. Perlis was awarded the Depression and Bipolar Support Alliance's Klerman Award; he now serves as a scientific advisor to the DBSA. ","",,
P05,static/images/speakers/ashley_beecy.jpeg,"",NewYork-Presbyterian,Ashley Beecy,"Dr. Ashley Beecy is the Medical Director of Artificial Intelligence (AI) Operations at NewYork-Presbyterian (NYP). She is a core member of NYP’s AI leadership team partnering with clinical, administrative and research leaders across the enterprise to drive digital transformation and deliver on NYP’s data and AI strategy. Dr. Beecy provides leadership in key areas including the governance, processes, and infrastructure to ensure the responsible and agile deployment of AI. She is responsible for NYP’s largest enterprise-wide AI initiative in collaboration with Cornell Tech and Cornell University. She is a thought leader and serves as a subject matter expert on multiple national AI collaboratives.","",,
